IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype S Turcan, D Rohle, A Goenka, LA Walsh, F Fang, E Yilmaz, C Campos, ... Nature 483 (7390), 479-483, 2012 | 2111 | 2012 |
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo O Abdel-Wahab, J Gao, M Adli, A Dey, T Trimarchi, YR Chung, C Kuscu, ... Journal of Experimental Medicine 210 (12), 2641-2659, 2013 | 359 | 2013 |
Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting Z Huang, L Cheng, OA Guryanova, Q Wu, S Bao Protein & cell 1 (7), 638-655, 2010 | 305 | 2010 |
Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3 OA Guryanova, Q Wu, L Cheng, JD Lathia, Z Huang, J Yang, ... Cancer cell 19 (4), 498-511, 2011 | 274 | 2011 |
Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT AV Gasparian, CA Burkhart, AA Purmal, L Brodsky, M Pal, M Saranadasa, ... Science translational medicine 3 (95), 95ra74-95ra74, 2011 | 255 | 2011 |
Elevated invasive potential of glioblastoma stem cells L Cheng, Q Wu, OA Guryanova, Z Huang, Q Huang, JN Rich, S Bao Biochemical and biophysical research communications 406 (4), 643-648, 2011 | 244 | 2011 |
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling OA Guryanova, K Shank, B Spitzer, L Luciani, RP Koche, ... Nature medicine 22 (12), 1488-1495, 2016 | 240 | 2016 |
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1 L Cheng, Q Wu, Z Huang, OA Guryanova, Q Huang, W Shou, JN Rich, ... The EMBO journal 30 (5), 800-813, 2011 | 206 | 2011 |
Loss of Dnmt3a immortalizes hematopoietic stem cells in vivo M Jeong, HJ Park, H Celik, EL Ostrander, JM Reyes, A Guzman, ... Cell reports 23 (1), 1-10, 2018 | 194 | 2018 |
Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells Z Huang, Q Wu, OA Guryanova, L Cheng, W Shou, JN Rich, S Bao Nature cell biology 13 (2), 142-152, 2011 | 174 | 2011 |
CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms SC Meyer, MD Keller, S Chiu, P Koppikar, OA Guryanova, F Rapaport, ... Cancer cell 28 (1), 15-28, 2015 | 150 | 2015 |
Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity Y Kim, E Kim, Q Wu, O Guryanova, M Hitomi, JD Lathia, D Serwanski, ... Genes & development 26 (11), 1247-1262, 2012 | 142 | 2012 |
Facilitates chromatin transcription complex is an “accelerator” of tumor transformation and potential marker and target of aggressive cancers H Garcia, JC Miecznikowski, A Safina, M Commane, A Ruusulehto, ... Cell reports 4 (1), 159-173, 2013 | 138 | 2013 |
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance Y Shi, OA Guryanova, W Zhou, C Liu, Z Huang, X Fang, X Wang, C Chen, ... Science translational medicine 10 (443), eaah6816, 2018 | 124 | 2018 |
Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers JL Glass, D Hassane, BJ Wouters, H Kunimoto, R Avellino, ... Cancer discovery 7 (8), 868-883, 2017 | 112 | 2017 |
Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells OA Guryanova, YK Lieu, FE Garrett-Bakelman, B Spitzer, JL Glass, ... Leukemia 30 (5), 1133-1142, 2016 | 72 | 2016 |
Complex mutual regulation of facilitates chromatin transcription (FACT) subunits on both mRNA and protein levels in human cells A Safina, H Garcia, M Commane, O Guryanova, S Degan, K Kolesnikova, ... Cell cycle 12 (15), 2423-2434, 2013 | 60 | 2013 |
Targeting transcription factor NFκB: comparative analysis of proteasome and IKK inhibitors AV Gasparian, OA Guryanova, DV Chebotaev, AA Shishkin, ... Cell Cycle 8 (10), 1559-1566, 2009 | 58 | 2009 |
The impact of inflammation-induced tumor plasticity during myeloid transformation A Yeaton, G Cayanan, S Loghavi, I Dolgalev, EM Leddin, CE Loo, ... Cancer discovery 12 (10), 2392-2413, 2022 | 35 | 2022 |
Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions P Nowialis, K Lopusna, J Opavska, SL Haney, A Abraham, P Sheng, ... Nature communications 10 (1), 4374, 2019 | 33 | 2019 |